Pulmatrix: Pulmatrix GAAP EPS of -$1.59, revenue of $1.6M

Pulmatrix is a Massachusetts-based biopharmaceutical firm that develops and commercializes therapies for the treatment of pulmonary and non-pulmonary diseases.